Delirium, Dementia, Amnestic, Cognitive Disorders  >>  BN82451  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
BN82451 / Ipsen
NCT02231580 / 2013-002899-41: Study Exploring Safety, Pharmacokinetic and Pharmacodynamic of BN82451 in Male Huntington's Disease Patients

Terminated
2a
17
Europe
BN82451B, Placebo
Ipsen
Huntington's Disease
03/16
03/16

Download Options